ASH 2019: New drug markedly improves overall survival in patients with AML in remission
Using an investigational oral form of azacitidine therapy, CC-486, significantly improved overall survival in older…
Using an investigational oral form of azacitidine therapy, CC-486, significantly improved overall survival in older…